Delivery Order SPE2DX22D0019-SPE2D826FCF73
- Not listed
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,287.20 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract represents a child award under Amerisourcebergen's parent company Cencora, Inc. and carries no set-aside designation. The delivery order falls under...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,122.80 by the Defense Logistics Agency Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price, non-set-aside contract represents a child order under Amerisourcebergen's parent organization Cencora, Inc. (doing business as Amerisourcebergen). The award is issued under Cencora's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $304,353.01 by the Defense Logistics Agency's Medical Supply Chain. The contract, awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a firm fixed-price delivery order with no set-aside designation. This award was competitively awarded and is structured as a child contract, with the parent entity being...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $40,347.72 on January 8, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, competitively awarded contract—not set aside for any specific business category—is scheduled for completion by January 9, 2026, with performance taking place at the awardee's Conshohocken location. The award represents a task order...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,545.28 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026. This competitively awarded, non-set-aside contract features firm fixed pricing and carries an ultimate completion date of January 8, 2026. The delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $943,263.97 by the Defense Logistics Agency's Medical Supply Chain on January 3, 2026. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, carries an ultimate completion date of January 5, 2026 and represents a non-competitive set-aside contract. The award supports the federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $167,368.32 on January 5, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is firm fixed price with no set-aside designation and an ultimate completion date of January 6, 2026. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,228.15 by the Defense Logistics Agency's Medical Supply Chain on December 9, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 10, 2025, and represents a child order under a larger indefinite delivery contract vehicle. The award is not set-aside and reflects the company's continued role...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCF73Delivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $166,128.90 by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 8, 2026, represents a child contract under the parent entity Cencora, Inc. (doing business as Amerisourcebergen). The award was made through competitive procurement with no set-aside designation, reflecting the contractor's capability to meet federal medical supply requirements in open competition. This delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This comprehensive IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains—to support military healthcare programs worldwide. The arrangement supports critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $166.1k | 1/6/26 |